Serum Institute to launch flu vaccine launch in July

摘要

The Serum Institute of India (SIIL) is launching its conjugate vaccine against haemothillus type B influenza in July under the brand name 'Hibpro'.Following clearance from the Drug Controller General of India,'Hibpro' - a vaccine for bacterial influenza -will be launched in India,as well as for export to neighbouring countries.The expected volume is 100-mn doses per year,according to Dr.S.S.Jadhav,Executive Director,SIIL.